cjc1295 ipamorelin austin cjc-1295 improves sleep quality & Therapy in CJC-1295 / Ipamorelin: Benefits, How – CJC-1295 No DAC + Ipamorelin

Generally well-tolerated in human trials at research doses with no major safety concerns reported [19]

ABLM Board Certified in Lifestyle Medicine

10mg per dose Primary Benefits Provides targeted, clean growth hormone stimulation through ghrelin receptor activation without affecting cortisol or prolactin levels

In animals (rats, pigs, dogs), ipamorelin does not raise ACTH or cortisol at doses up to 200 its GH-release ED (Raun 1998)

The original sponsor (EMD Serono, later Theratechnologies) didnt pursue a broader obesity indication, likely because the trial cost and competitive landscape against GLP-1s made it economically unattractive